Entero Therapeutics, Inc. (ENTO)

NASDAQ: ENTO · IEX Real-Time Price · USD

1.800

+0.030 (1.69%)

At close: Jun 25, 2024, 4:00 PM

1.760

-0.040 (-2.22%)

Pre-market: Jun 26, 2024, 8:51 AM EDT

Entero Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Selling, General & Admin	10.74	11.99	18.38	7.29	6.06	Upgrade
Research & Development	5.03	0.69	38.32	19.14	8.68	Upgrade
Other Operating Expenses	0	0	2.35	0	0	Upgrade
Operating Expenses	15.77	12.68	59.06	26.43	14.74	Upgrade
Operating Income	-15.77	-12.68	-59.06	-26.43	-14.74	Upgrade
Interest Expense / Income	0.02	0.02	0.01	5.84	0.43	Upgrade
Other Expense / Income	0	1.94	-0.53	0.4	-	Upgrade
Pretax Income	-15.79	-14.63	-58.54	-32.67	-15.18	Upgrade
Net Income	-15.79	-14.63	-58.54	-32.67	-15.18	Upgrade
Preferred Dividends	0.31	0.34	25.98	9.06	0	Upgrade
Net Income Common	-16.1	-14.97	-84.52	-41.73	-15.18	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change	836.57%	1589.98%	213.88%	26.78%	45.11%	Upgrade
EPS (Basic)	-47.88	-416.94	-39770.60	-61656.68	-28560.31	Upgrade
EPS (Diluted)	-47.88	-416.94	-39770.60	-61656.68	-28560.31	Upgrade
Free Cash Flow	-12.38	-22.34	-32.36	-11.13	-14.06	Upgrade
Free Cash Flow Per Share	-36.80	-622.19	-15226.08	-16445.22	-26328.25	Upgrade
EBITDA	-15.74	-14.58	-57.98	-26.27	-13.72	Upgrade
Depreciation & Amortization	0.03	0.03	0.54	0.56	1.02	Upgrade
EBIT	-15.77	-14.61	-58.53	-26.83	-14.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).